Atlas Trials

Repurposing Dexmedetomidine as an Orally Administered Sleep Therapeutic

Clinical trial NCT02818569 · COMPLETED

Trial details

NCT number
NCT02818569
Sponsor
Massachusetts General Hospital
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
SleepInsomnia
Start date
2016-10-01
Primary completion
2018-06-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.